Jacquie Ross | Vice President, Investor Relations |
Daniel O'Day | Chairman and Chief Executive Officer |
Johanna Mercier | Chief Commercial Officer |
Merdad Parsey | Chief Medical Officer |
Andrew Dickinson | Chief Financial Officer |
Cindy Perettie | Executive Vice President, Kite |
Geoff Meacham | Bank of America |
Chris Schott | JPMorgan |
Tyler Van Buren | TD Cowen |
Terrence Flynn | Morgan Stanley |
Bill Jahangiri | Truist |
Brian Abrahams | RBC Capital Markets |
Carter Gould | Barclays |
Matthew Dellatorre | Goldman Sachs |
Colin Bristow | UBS |
Evan Seigerman | BMO Capital Markets |
Joseph Catanzaro | Piper Sandler |
Mohit Bansal | Wells Fargo |
Simon Baker | Redburn |
Hello, everyone. Thank you for attending Gilead Sciences' Second Quarter 2023 Earnings Conference Call. My name is Sarah and I'll be your moderator today. All lines will be muted during the presentation portion of the call with an opportunity for questions and answers at the end. [Operator Instructions]